November 23, 2020
Pfizer has applied to U.S. health regulators for emergency use authorization (EUA) of its COVID-19 vaccine, with an expected approval by mid-December and the anticipated delivery of an estimated 50 million vaccines by year end.
November 19, 2020
According to Nasdaq contributor Nozomi Hayase, the American people showed a vote of no confidence in the integrity of the electoral process during the 2020 U.S. Presidential election, and, as a result, the bitcoin price surged to over $15,000, marking the highest mark since its all-time high in 2017.
November 18, 2020
Following a move from JPMorgan Chase & Co, who has committed to reduce emissions by 2030, other major financial players, including Blackrock, UBS, and Goldman Sachs, are demonstrating an embrace of stakeholder capitalism, shifting the purpose of a business from serving shareholders to committing to deliver value to all stakeholders while focusing on the importance of corporate social purpose.
Pfizer and Biontech Reach an Agreement to Supply EU with 200 Million Doses of Their Covid-19 Vaccine
November 16, 2020
Pfizer and BioNTech SE announced that they have reached an agreement with the European Commission to supply 200 million doses of their investigational BNT162b2 mRNA-based vaccine candidate against SARS-CoV-2 to European Union (EU) Member States starting by the end of 2020 depending on the clinical success and regulatory authority.
November 12, 2020
Following an inquiry which included the procurement of a massive data set from Amazon, European Union regulators filed antitrust charges against the company, saying the online retail giant broke competition laws by using its access to data from companies that sell products on its platform to gain an unfair advantage over them.